Evidence map›Paper›PMID 40837934›Full record

ReviewCureus2025

Outcomes of Bariatric Surgery in Hypothyroid Patients Taking Levothyroxine: A Systematic Review and Meta-Analysis.

Malak Maaz Hassan, Zubair Ahmad, Malak Bilal Hassan, Zoha Tasawar, Qudsia Hassan, Shafiq Ur Rahman

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Malak Maaz HassanDepartment of General Surgery, Hayatabad Medical Complex, Peshawar, PAK.
Zubair AhmadDepartment of Internal Medicine, Hayatabad Medical Complex, Peshawar, PAK.
Malak Bilal HassanDepartment of General Surgery, Saidu Teaching Hospital, Swat, PAK.
Zoha TasawarDepartment of General Surgery, Saidu Teaching Hospital, Swat, PAK.
Qudsia HassanDepartment of General Surgery, Saidu Teaching Hospital, Swat, PAK.
Shafiq Ur RahmanDepartment of General Surgery, Saidu Teaching Hospital, Swat, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is among the most serious challenges faced by global public health. Because of the growing rate of obesity, the number of bariatric surgeries as an effective treatment is increasing day by day. Bariatric surgeries lead to significant anatomical and physiological changes in the gastrointestinal tract. Oral levothyroxine has been the treatment of choice for hypothyroidism for many years and is a narrow therapeutic index (NTI) drug, and its absorption can be significantly influenced by alterations in gastrointestinal physiology and anatomy. The aim of this study was to evaluate the impact of bariatric surgery on levothyroxine requirements and to assess changes in thyroid function tests. A literature search was conducted using Medical Subject Headings (MeSH) terms and relevant keywords related to surgery, bariatric procedures, hypothyroidism, and levothyroxine across PubMed, Embase, Cochrane, and ClinicalTrials.gov from inception to May 2025. Cohort studies comparing levothyroxine dose and thyroid function tests before and after bariatric surgery were included. A random-effects model using the inverse variance method was applied to account for clinical and methodological heterogeneity. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. Heterogeneity was assessed using the Chi-square (χ²) test, I² statistic, and Tau² for between-study variance. The pooled effect was tested using a Z-test, with significance set at P < 0.05. Seventeen cohort studies with 922 patients were included in this meta-analysis. This study showed a mild and non-significant reduction in the dose of levothyroxine after bariatric surgery (SMD of 0.19 (95% CI:-0.05 to 0.42, p = 0.1) and I² = 84%) and indicated a very small and statistically non-significant improvement in favor of post-operative thyroid-stimulating hormone (TSH) (SMD is 0.03 (95% CI: -0.20 to 0.27), P=0.78, I² = 80%). There was a statistical improvement in triiodothyronine (T3) levels (SMD = 0.60; 95% CI: 0.03 to 1.17; p = 0.04 and I² = 91%) and no significant difference in T4 (SMD = 0.01; 95% CI: -0.58 to 0.60; p = 0.97; I² = 80%) levels after surgery. This meta-analysis suggests bariatric surgery may modestly reduce levothyroxine dose and improve T3 levels in hypothyroid patients, with no significant changes in TSH or thyroxine (T4). High heterogeneity and limited study quality highlight the need for individualized dose adjustment and further robust research.

Indexed as

bariatric surgeryhypothyroidismlevothyroxine therapythyroid-stimulating hormone (tsh)thyroxine (t4)triiodothyronine (t3)

Identifiers

PMID40837934
PMCPMC12362319

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.